Logo for Nxera Pharma Co. Ltd

Nxera Pharma Investor Relations Material

Latest events

Logo for Nxera Pharma Co. Ltd

Q4 2024

Nxera Pharma
Logo for Nxera Pharma

Q4 2024

14 Feb, 2025
Logo for Nxera Pharma

Status Update

6 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Nxera Pharma Co. Ltd

Access all reports
Sosei Group Corporation, also known as Sosei Heptares, is a biopharmaceutical company that specializes in the development of drugs using its proprietary G protein-coupled receptor (GPCR) targeted StaR technology and structure-based drug discovery (SBDD) platform. The company's product lineup includes medicines such as Ultibro, Seebri, Enerzair, Breezhaler, Pivlaz, and Oravi. Sosei Group Corporation is headquartered in Chiyoda-ku, Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.